급성 허혈성 뇌졸중 진단 시장 : 기술별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Acute Ischemic Stroke Diagnosis Market By Technology , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,279,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,518,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

급성 허혈성 뇌졸중 진단 시장

급성 허혈성 뇌졸중 진단 시장은 2023년 21억 달러로 평가되며, 2024년부터 2033년까지 연평균 5.7% 성장하여 2033년에는 36억 달러에 달할 것으로 예측됩니다.

급성 허혈성 뇌졸중(AIS)은 뇌로 가는 혈류가 갑자기 차단되어 신경 기능 장애를 일으키는 치명적인 질환입니다. 일반적으로 혈전이나 혈전으로 인해 혈전이 발생하여 뇌조직의 허혈이나 경색을 유발합니다. AIS의 가장 흔한 증상은 갑작스러운 쇠약감, 대화와 이해의 어려움, 신체 한쪽의 마비, 시력 장애, 심한 두통, 현기증 등이며, AIS의 즉각적인 진단을 위해서는 임상 평가와 CT 또는 MRI를 통한 신경 영상 진단이 필요하며, 이는 혈류를 적시에 회복하고 뇌 손상을 줄이는 데 매우 중요합니다. 매우 중요합니다.

특히 노년층의 급성 허혈성 뇌졸중(AIS) 유병률 증가로 급성 허혈성 뇌졸중 진단에 대한 수요가 증가하고 있습니다. 전 세계적으로 노인 인구가 급격히 증가하고 있으며, 역동적인 라이프스타일의 변화로 인해 노인들 사이에서 생명을 위협하는 질병의 발생이 증가하고 있습니다. 또한, 의료 및 진단 기술에 대한 지출이 급증하고 있는 것도 시장 성장의 주요 원동력이 되고 있습니다. 동맥 스핀 라벨링과 같은 비침습적 이미징 기술은 최근 AIS 진단의 최신 트렌드입니다. 이러한 기술은 비침습적으로 뇌 혈류를 측정할 수 있기 때문에 빠르고 정확한 진단으로 조직의 생존 가능성을 평가하는 데 도움이 됩니다.

그러나 이러한 첨단 진단 기술 관련 비용이 매우 비싸기 때문에 저소득층이 그 혜택을 누릴 수 없어 시장 개척에 걸림돌이 되고 있습니다. 또한, 급성 허혈성 뇌졸중 진단에 대한 보험급여가 매우 불일치하고, 여러 가지 문제점이 있어 시장 성장을 저해하고 있습니다. 반면, AIS의 유병률을 낮추기 위한 정부의 일관된 노력은 시장에 유리한 기회를 제공할 것으로 예상됩니다. 예를 들어, 유럽 뇌졸중기구는 2018년 유럽 뇌졸중 행동 계획이라는 이니셔티브를 시작하여 2030년까지 뇌졸중 예방 행동을 개선하는 것을 목표로 하고 있습니다.

부문 리뷰

급성 허혈성 뇌졸중 진단 시장은 기술, 최종사용자, 지역으로 구분됩니다. 기술별로는 CT, MRI, 경동맥 초음파, 뇌혈관조영술, 심전도, 심초음파, 기타로 분류됩니다. 최종사용자별로는 병원 및 클리닉, 외래 수술센터, 진단연구소 및 영상 진단센터, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

기술별로는 CT(컴퓨터 단층촬영) 분야가 2023년 시장에서 높은 점유율을 차지했습니다.

최종사용자별로는 병원 및 클리닉 부문이 2023년 최대 주주로 부상했습니다.

지역별로는 북미가 2023년까지 가장 높은 수익을 올렸습니다.

본 보고서의 커스터마이징이 가능합니다(추가 비용과 일정이 필요합니다.).

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확장 목록
• 과거 시장 데이터

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 급성 허혈성 뇌졸중 진단 시장 : 기술별

• 시장 개요
• 컴퓨터 단층촬영
• 자기공명영상법
• 경동맥 초음파
• 뇌혈관 촬영
• 심전도
• 심장초음파 검사
• 기타

제5장 급성 허혈성 뇌졸중 진단 시장 : 최종사용자별

• 시장 개요
• 병원 및 진료소
• 외래 수술 센터
• 진단 연구소 및 영상 진단 센터
• 기타

제6장 급성 허혈성 뇌졸중 진단 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 급성 허혈성 뇌졸중 진단 시장
  • 캐나다 급성 허혈성 뇌졸중 진단 시장
  • 멕시코 급성 허혈성 뇌졸중 진단 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일의 급성 허혈성 뇌졸중 진단 시장
  • 프랑스 급성 허혈성 뇌졸중 진단 시장
  • 영국 급성 허혈성 뇌졸중 진단 시장
  • 이탈리아 급성 허혈성 뇌졸중 진단 시장
  • 스페인 급성 허혈성 뇌졸중 진단 시장
  • 기타 유럽의 허혈성 뇌졸중 진단 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본의 급성 허혈성 뇌졸중 진단 시장
  • 중국의 급성 허혈성 뇌졸중 진단 시장
  • 인도의 허혈성 뇌졸중 진단 시장
  • 호주의 허혈성 뇌졸중 진단 시장
  • 한국의 급성 허혈성 뇌졸중 진단 시장
  • 기타 아시아태평양의 허혈성 뇌졸중 진단 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 허혈성 뇌졸중 진단 시장
  • 사우디아라비아의 허혈성 뇌졸중 진단 시장
  • 남아프리카공화국의 허혈성 뇌졸중 진단 시장
  • 기타 라틴아메리카, 중동 및 아프리카의 급성 허혈성 뇌졸중 진단 시장

제7장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제8장 기업 개요

• Koninklijke Philips N.V.
• GE Healthcare
• Canon Inc.
• Simens
• Terumo Corporation
• Stryker
• Fujifilm Holdings Corporation
• Samsung Electronics Co. Ltd
• F. Hoffmann-La Roche Ltd
• Boehringer Ingelheim International GmbH

ksm

영문 목차

영문목차

Acute Ischemic Stroke Diagnosis Market

The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.

Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.

However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.

Segment Review

The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.

Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.

Region wise, North America is poised to be the highest revenue generator by 2023.

Competition Analysis

The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data

Key Market Segments

By Technology

• Computed Tomography
• Magnetic Resonance Imaging
• Carotid Ultrasound
• Cerebral Angiography
• Electrocardiography
• Echocardiography
• Others

By End User

• Hospitals and Clinics
• Ambulatory Surgery Centers
• Diagnostic Laboratories and Imaging Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Koninklijke Philips N.V.
• GE Healthcare
• Canon Inc.
• Simens
• Terumo Corporation
• Stryker
• Fujifilm Holdings Corporation
• Samsung Electronics Co. Ltd
• F. Hoffmann-La Roche Ltd
• Boehringer Ingelheim International GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Technology
• 4.2. Computed Tomography
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Magnetic Resonance Imaging
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Carotid Ultrasound
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Cerebral Angiography
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. Electrocardiography
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country
• 4.7. Echocardiography
  • 4.7.1. Key Market Trends, Growth Factors and Opportunities
  • 4.7.2. Market Size and Forecast, By Region
  • 4.7.3. Market Share Analysis, By Country
• 4.8. Others
  • 4.8.1. Key Market Trends, Growth Factors and Opportunities
  • 4.8.2. Market Size and Forecast, By Region
  • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By End User
• 5.2. Hospitals And Clinics
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Ambulatory Surgery Centers
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Diagnostic Laboratories And Imaging Centers
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Others
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Region
• 6.2. North America
  • 6.2.1. Key Market Trends and Opportunities
  • 6.2.2. Market Size and Forecast, By Technology
  • 6.2.3. Market Size and Forecast, By End User
  • 6.2.4. Market Size and Forecast, By Country
  • 6.2.5. U.S. Acute Ischemic Stroke Diagnosis Market
    • 6.2.5.1. Market Size and Forecast, By Technology
    • 6.2.5.2. Market Size and Forecast, By End User
  • 6.2.6. Canada Acute Ischemic Stroke Diagnosis Market
    • 6.2.6.1. Market Size and Forecast, By Technology
    • 6.2.6.2. Market Size and Forecast, By End User
  • 6.2.7. Mexico Acute Ischemic Stroke Diagnosis Market
    • 6.2.7.1. Market Size and Forecast, By Technology
    • 6.2.7.2. Market Size and Forecast, By End User
• 6.3. Europe
  • 6.3.1. Key Market Trends and Opportunities
  • 6.3.2. Market Size and Forecast, By Technology
  • 6.3.3. Market Size and Forecast, By End User
  • 6.3.4. Market Size and Forecast, By Country
  • 6.3.5. Germany Acute Ischemic Stroke Diagnosis Market
    • 6.3.5.1. Market Size and Forecast, By Technology
    • 6.3.5.2. Market Size and Forecast, By End User
  • 6.3.6. France Acute Ischemic Stroke Diagnosis Market
    • 6.3.6.1. Market Size and Forecast, By Technology
    • 6.3.6.2. Market Size and Forecast, By End User
  • 6.3.7. UK Acute Ischemic Stroke Diagnosis Market
    • 6.3.7.1. Market Size and Forecast, By Technology
    • 6.3.7.2. Market Size and Forecast, By End User
  • 6.3.8. Italy Acute Ischemic Stroke Diagnosis Market
    • 6.3.8.1. Market Size and Forecast, By Technology
    • 6.3.8.2. Market Size and Forecast, By End User
  • 6.3.9. Spain Acute Ischemic Stroke Diagnosis Market
    • 6.3.9.1. Market Size and Forecast, By Technology
    • 6.3.9.2. Market Size and Forecast, By End User
  • 6.3.10. Rest of Europe Acute Ischemic Stroke Diagnosis Market
    • 6.3.10.1. Market Size and Forecast, By Technology
    • 6.3.10.2. Market Size and Forecast, By End User
• 6.4. Asia-Pacific
  • 6.4.1. Key Market Trends and Opportunities
  • 6.4.2. Market Size and Forecast, By Technology
  • 6.4.3. Market Size and Forecast, By End User
  • 6.4.4. Market Size and Forecast, By Country
  • 6.4.5. Japan Acute Ischemic Stroke Diagnosis Market
    • 6.4.5.1. Market Size and Forecast, By Technology
    • 6.4.5.2. Market Size and Forecast, By End User
  • 6.4.6. China Acute Ischemic Stroke Diagnosis Market
    • 6.4.6.1. Market Size and Forecast, By Technology
    • 6.4.6.2. Market Size and Forecast, By End User
  • 6.4.7. India Acute Ischemic Stroke Diagnosis Market
    • 6.4.7.1. Market Size and Forecast, By Technology
    • 6.4.7.2. Market Size and Forecast, By End User
  • 6.4.8. Australia Acute Ischemic Stroke Diagnosis Market
    • 6.4.8.1. Market Size and Forecast, By Technology
    • 6.4.8.2. Market Size and Forecast, By End User
  • 6.4.9. South Korea Acute Ischemic Stroke Diagnosis Market
    • 6.4.9.1. Market Size and Forecast, By Technology
    • 6.4.9.2. Market Size and Forecast, By End User
  • 6.4.10. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis Market
    • 6.4.10.1. Market Size and Forecast, By Technology
    • 6.4.10.2. Market Size and Forecast, By End User
• 6.5. LAMEA
  • 6.5.1. Key Market Trends and Opportunities
  • 6.5.2. Market Size and Forecast, By Technology
  • 6.5.3. Market Size and Forecast, By End User
  • 6.5.4. Market Size and Forecast, By Country
  • 6.5.5. Brazil Acute Ischemic Stroke Diagnosis Market
    • 6.5.5.1. Market Size and Forecast, By Technology
    • 6.5.5.2. Market Size and Forecast, By End User
  • 6.5.6. Saudi Arabia Acute Ischemic Stroke Diagnosis Market
    • 6.5.6.1. Market Size and Forecast, By Technology
    • 6.5.6.2. Market Size and Forecast, By End User
  • 6.5.7. South Africa Acute Ischemic Stroke Diagnosis Market
    • 6.5.7.1. Market Size and Forecast, By Technology
    • 6.5.7.2. Market Size and Forecast, By End User
  • 6.5.8. Rest of LAMEA Acute Ischemic Stroke Diagnosis Market
    • 6.5.8.1. Market Size and Forecast, By Technology
    • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top Winning Strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

• 8.1. Koninklijke Philips N.V.
  • 8.1.1. Company Overview
  • 8.1.2. Key Executives
  • 8.1.3. Company Snapshot
  • 8.1.4. Operating Business Segments
  • 8.1.5. Product Portfolio
  • 8.1.6. Business Performance
  • 8.1.7. Key Strategic Moves and Developments
• 8.2. GE Healthcare
  • 8.2.1. Company Overview
  • 8.2.2. Key Executives
  • 8.2.3. Company Snapshot
  • 8.2.4. Operating Business Segments
  • 8.2.5. Product Portfolio
  • 8.2.6. Business Performance
  • 8.2.7. Key Strategic Moves and Developments
• 8.3. Canon Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Key Executives
  • 8.3.3. Company Snapshot
  • 8.3.4. Operating Business Segments
  • 8.3.5. Product Portfolio
  • 8.3.6. Business Performance
  • 8.3.7. Key Strategic Moves and Developments
• 8.4. Simens
  • 8.4.1. Company Overview
  • 8.4.2. Key Executives
  • 8.4.3. Company Snapshot
  • 8.4.4. Operating Business Segments
  • 8.4.5. Product Portfolio
  • 8.4.6. Business Performance
  • 8.4.7. Key Strategic Moves and Developments
• 8.5. Terumo Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Key Executives
  • 8.5.3. Company Snapshot
  • 8.5.4. Operating Business Segments
  • 8.5.5. Product Portfolio
  • 8.5.6. Business Performance
  • 8.5.7. Key Strategic Moves and Developments
• 8.6. Stryker
  • 8.6.1. Company Overview
  • 8.6.2. Key Executives
  • 8.6.3. Company Snapshot
  • 8.6.4. Operating Business Segments
  • 8.6.5. Product Portfolio
  • 8.6.6. Business Performance
  • 8.6.7. Key Strategic Moves and Developments
• 8.7. Fujifilm Holdings Corporation
  • 8.7.1. Company Overview
  • 8.7.2. Key Executives
  • 8.7.3. Company Snapshot
  • 8.7.4. Operating Business Segments
  • 8.7.5. Product Portfolio
  • 8.7.6. Business Performance
  • 8.7.7. Key Strategic Moves and Developments
• 8.8. Samsung Electronics Co. Ltd
  • 8.8.1. Company Overview
  • 8.8.2. Key Executives
  • 8.8.3. Company Snapshot
  • 8.8.4. Operating Business Segments
  • 8.8.5. Product Portfolio
  • 8.8.6. Business Performance
  • 8.8.7. Key Strategic Moves and Developments
• 8.9. F. Hoffmann-La Roche Ltd
  • 8.9.1. Company Overview
  • 8.9.2. Key Executives
  • 8.9.3. Company Snapshot
  • 8.9.4. Operating Business Segments
  • 8.9.5. Product Portfolio
  • 8.9.6. Business Performance
  • 8.9.7. Key Strategic Moves and Developments
• 8.10. Boehringer Ingelheim International GmbH
  • 8.10.1. Company Overview
  • 8.10.2. Key Executives
  • 8.10.3. Company Snapshot
  • 8.10.4. Operating Business Segments
  • 8.10.5. Product Portfolio
  • 8.10.6. Business Performance
  • 8.10.7. Key Strategic Moves and Developments

관련자료